Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

MicroRNA expression changes after lung cancer resection: a follow-up study.

Leidinger P, Keller A, Backes C, Huwer H, Meese E.

RNA Biol. 2012 Jun;9(6):900-10. doi: 10.4161/rna.20107. Epub 2012 Jun 1.

PMID:
22664918
2.

Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.

Aushev VN, Zborovskaya IB, Laktionov KK, Girard N, Cros MP, Herceg Z, Krutovskikh V.

PLoS One. 2013 Oct 9;8(10):e78649. doi: 10.1371/journal.pone.0078649. eCollection 2013.

3.

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.

Tang D, Shen Y, Wang M, Yang R, Wang Z, Sui A, Jiao W, Wang Y.

Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.

PMID:
23462458
4.

Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.

Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ, Hong SJ.

J Hematol Oncol. 2014 Jan 10;7:6. doi: 10.1186/1756-8722-7-6.

5.

High-throughput miRNA profiling of human melanoma blood samples.

Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, Lenhof HP, Meese E.

BMC Cancer. 2010 Jun 7;10:262. doi: 10.1186/1471-2407-10-262.

6.

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG.

Cancer Res. 2009 Jul 15;69(14):5776-83. doi: 10.1158/0008-5472.CAN-09-0587. Epub 2009 Jul 7.

7.

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E.

RNA Biol. 2011 May-Jun;8(3):506-16. Epub 2011 May 1.

PMID:
21558792
8.

Progressive lung cancer determined by expression profiling and transcriptional regulation.

Han N, Dol Z, Vasieva O, Hyde R, Liloglou T, Raji O, Brambilla E, Brambilla C, Martinet Y, Sozzi G, Risch A, Montuenga LM; EUELC Consortium, Brass A, Field JK.

Int J Oncol. 2012 Jul;41(1):242-52. doi: 10.3892/ijo.2012.1421. Epub 2012 Mar 28.

PMID:
22469662
9.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK.

Med Oncol. 2012 Jun;29(2):618-26. doi: 10.1007/s12032-011-9923-y. Epub 2011 Apr 24.

PMID:
21516486
10.

MicroRNA expression profiles of whole blood in lung adenocarcinoma.

Patnaik SK, Yendamuri S, Kannisto E, Kucharczuk JC, Singhal S, Vachani A.

PLoS One. 2012;7(9):e46045. doi: 10.1371/journal.pone.0046045. Epub 2012 Sep 28.

11.

Longitudinal study on circulating miRNAs in patients after lung cancer resection.

Leidinger P, Galata V, Backes C, Stähler C, Rheinheimer S, Huwer H, Meese E, Keller A.

Oncotarget. 2015 Jun 30;6(18):16674-85.

12.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

13.

miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.

Dacic S, Kelly L, Shuai Y, Nikiforova MN.

Mod Pathol. 2010 Dec;23(12):1577-82. doi: 10.1038/modpathol.2010.152. Epub 2010 Sep 3.

14.

miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments.

Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E.

BMC Cancer. 2009 Oct 6;9:353. doi: 10.1186/1471-2407-9-353.

15.

The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases.

Leidinger P, Backes C, Blatt M, Keller A, Huwer H, Lepper P, Bals R, Meese E.

Mol Cancer. 2014 Aug 30;13:202. doi: 10.1186/1476-4598-13-202.

16.

Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.

Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY.

Tumour Biol. 2012 Dec;33(6):1933-42. doi: 10.1007/s13277-012-0454-8. Epub 2012 Jul 19.

PMID:
22811001
17.

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers.

Xing L, Todd NW, Yu L, Fang H, Jiang F.

Mod Pathol. 2010 Aug;23(8):1157-64. doi: 10.1038/modpathol.2010.111. Epub 2010 Jun 4.

18.

Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.

Ahmed FE, Amed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Allison RR.

Cancer Genomics Proteomics. 2012 Jul-Aug;9(4):179-92.

PMID:
22798503
19.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

20.

Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.

D'Amico TA, Brooks KR, Joshi MB, Conlon D, Herndon J 2nd, Petersen RP, Harpole DH Jr.

Ann Thorac Surg. 2006 Jun;81(6):1982-7; discussion 1987.

PMID:
16731117
Items per page

Supplemental Content

Write to the Help Desk